Literature DB >> 3102313

Inhibition and activation of UDP-glucuronyltransferase in alloxanic-diabetic rats.

P Vega, C Gaule, E Sanchez, E del Villar.   

Abstract

Short or long term alloxan diabetes produced activation of oestrone and morphine glucuronidation and inhibition of p-nitrophenol glucuronidation in rat liver microsomes. Insulin treatment restored decreased glucuronyltransferase (GT) activity for p-nitrophenol and it did not abolish diabetes activation on oestrone glucuronidation. Triton X-100 detergent activation reduced differences between normal, diabetic and insulin treated rats in the glucuronidation rates of the substrates assayed. 1,4-Benzodiazepines inhibited morphine GT activity and stimulated oestrone GT activity in normal, diabetic and insulin treated diabetic rats. Activation and inhibition of GT activities for oestrone and xenobiotics in diabetes mellitus appears to be related with membrane perturbations of liver microsomes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3102313     DOI: 10.1016/0306-3623(86)90293-4

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  3 in total

1.  Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients.

Authors:  Teresa Maria J P Carvalho; Ricardo de Carvalho Cavalli; Sérgio P Cunha; Cláudia O de Baraldi; Maria P Marques; Natalícia J Antunes; Ana Leonor P C Godoy; Vera Lucia Lanchote
Journal:  Eur J Clin Pharmacol       Date:  2010-09-17       Impact factor: 2.953

2.  Diabetes in female rats; changes in liver microsomal aminopyrine N-demethylase and UDP-glucuronyl transferase activities.

Authors:  E Del Villar; P Vega; C Gaule; E Sanchez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

3.  Disposition of lorazepam in diabetes: differences between patients treated with beef/pork and human insulins.

Authors:  R J Herman; A Chaudhary; C B Szakacs; D Woo; R Lane; M A Boctor
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.